PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Na Lv

Department of Clinical Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China.

Human Vaccines & Immunotherapeutics

Modelling study based on a single trial's survival data, assessing cost-effectiveness in a specific healthcare system; does not itself evaluate clinical outcomes and depends on external trial evidence and assumptions.

PreliminaryYuan Gao Head and Neck Neoplasms Head and Neck Cancer

Reported

Incremental cost (finotonlimab +…$26,072.18

Total cost finotonlimab + chemoth…$36,996.99

Total cost chemotherapy alone$10,924.81

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support